Direct inhibition of the notch transcription factor complex

Direct inhibition of the notch transcription factor complex

Play all audios:

Loading...

ABSTRACT Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable


for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized α-helical peptides that target a critical protein–protein interface in the


NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex.


Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells


with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in


cultured cells and in a mouse model of NOTCH1-driven T-ALL. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS


OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on


SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about


institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS AFFINITY-MATURED DLL4 LIGANDS AS BROAD-SPECTRUM MODULATORS OF NOTCH SIGNALING


Article 01 September 2022 STRUCTURAL INSIGHTS INTO HUMAN BRACHYURY DNA RECOGNITION AND DISCOVERY OF PROGRESSIBLE BINDERS FOR CANCER THERAPY Article Open access 14 February 2025 SELECTIVE


INHIBITION OF STAT3 SIGNALING USING MONOBODIES TARGETING THE COILED-COIL AND N-TERMINAL DOMAINS Article Open access 17 August 2020 ACCESSION CODES PRIMARY ACCESSIONS GENE EXPRESSION OMNIBUS


* GSE18198 * GSE18351 PROTEIN DATA BANK * 2F8X DATA DEPOSITS All microarray data has been deposited to the Gene Expression Omnibus at the National Center for Biotechnology Information under


accession numbers GSE18198 and GSE18351. REFERENCES * Darnell, J. E. Transcription factors as targets for cancer therapy. _Nature Rev. Cancer_ 2, 740–749 (2002) Article  CAS  Google Scholar


  * Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. _Science_ 284, 770–776 (1999) Article  ADS  CAS  Google


Scholar  * Bray, S. J. Notch signalling: a simple pathway becomes complex. _Nature Rev. Mol. Cell Biol._ 7, 678–689 (2006) Article  CAS  Google Scholar  * Struhl, G. & Greenwald, I.


Presenilin is required for activity and nuclear access of Notch in _Drosophila_. _Nature_ 398, 522–525 (1999) Article  ADS  CAS  Google Scholar  * Ye, Y., Lukinova, N. & Fortini, M. E.


Neurogenic phenotypes and altered Notch processing in _Drosophila_ Presenilin mutants. _Nature_ 398, 525–529 (1999) Article  ADS  CAS  Google Scholar  * De Strooper, B. et al. A


presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. _Nature_ 398, 518–522 (1999) Article  ADS  CAS  Google Scholar  * Fortini, M. E. &


Artavanis-Tsakonas, S. The suppressor of hairless protein participates in notch receptor signaling. _Cell_ 79, 273–282 (1994) Article  CAS  Google Scholar  * Petcherski, A. G. & Kimble,


J. Mastermind is a putative activator for Notch. _Curr. Biol._ 10, R471–R473 (2000) Article  CAS  Google Scholar  * Wu, L. et al. MAML1, a human homologue of _Drosophila_ Mastermind, is a


transcriptional co-activator for NOTCH receptors. _Nature Genet._ 26, 484–489 (2000) Article  CAS  Google Scholar  * Li, L. et al. Alagille syndrome is caused by mutations in human


_Jagged1_, which encodes a ligand for Notch1. _Nature Genet._ 16, 243–251 (1997) Article  CAS  Google Scholar  * Joutel, A. et al. _Notch3_ mutations in CADASIL, a hereditary adult-onset


condition causing stroke and dementia. _Nature_ 383, 707–710 (1996) Article  ADS  CAS  Google Scholar  * Garg, V. et al. Mutations in _NOTCH1_ cause aortic valve disease. _Nature_ 437,


270–274 (2005) Article  ADS  CAS  Google Scholar  * Ellisen, L. W. et al. _TAN_-1, the human homolog of the _Drosophila notch_ gene, is broken by chromosomal translocations in T


lymphoblastic neoplasms. _Cell_ 66, 649–661 (1991) Article  CAS  Google Scholar  * Weng, A. P. et al. Activating _mutations_ of NOTCH1 in human T cell acute lymphoblastic leukemia. _Science_


306, 269–271 (2004) Article  ADS  CAS  Google Scholar  * O’Neil, J. et al. _FBW7_ mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors. _J.


Exp. Med._ 204, 1813–1824 (2007) Article  Google Scholar  * Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. _J. Cell Biol._ 167,


215–221 (2004) Article  CAS  Google Scholar  * Fre, S. et al. Notch signals control the fate of immature progenitor cells in the intestine. _Nature_ 435, 964–968 (2005) Article  ADS  CAS 


Google Scholar  * Uyttendaele, H. et al. _Notch4/int-3_, a mammary proto-oncogene, is an endothelial cell-specific mammalian _Notch_ gene. _Development_ 122, 2251–2259 (1996) CAS  PubMed 


Google Scholar  * Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. _Nature Genet._ 33, 416–421 (2003) Article  CAS  Google Scholar  * Konishi, J. et al. γ-secretase


inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. _Cancer Res._ 67, 8051–8057 (2007) Article  CAS  Google Scholar  * Nefedova, Y., Cheng, P., Alsina, M.,


Dalton, W. S. & Gabrilovich, D. I. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. _Blood_


103, 3503–3510 (2004) Article  CAS  Google Scholar  * Park, J. T. et al. _Notch3_ gene amplification in ovarian cancer. _Cancer Res._ 66, 6312–6318 (2006) Article  CAS  Google Scholar  *


Miyamoto, Y. et al. Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis. _Cancer Cell_ 3, 565–576 (2003) Article  CAS  Google Scholar  *


Seiffert, D. et al. Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors. _J. Biol. Chem._ 275, 34086–34091 (2000) Article  CAS  Google Scholar  * Dovey, H. F. et al.


Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. _J. Neurochem._ 76, 173–181 (2001) Article  CAS  Google Scholar  * Lleó, A. Activity of γ-secretase on substrates


other than APP. _Curr. Top. Med. Chem._ 8, 9–16 (2008) Article  MathSciNet  Google Scholar  * Riccio, O. et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1


and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. _EMBO Rep._ 9, 377–383 (2008) Article  CAS  Google Scholar  * Maillard, I. et al. Mastermind critically


regulates Notch-mediated lymphoid cell fate decisions. _Blood_ 104, 1696–1702 (2004) Article  CAS  Google Scholar  * Weng, A. P. et al. Growth suppression of pre-T acute lymphoblastic


leukemia cells by inhibition of notch signaling. _Mol. Cell. Biol._ 23, 655–664 (2003) Article  CAS  Google Scholar  * Nam, Y., Sliz, P., Song, L., Aster, J. C. & Blacklow, S. C.


Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. _Cell_ 124, 973–983 (2006) Article  CAS  Google Scholar  * Wilson, J. J. &


Kovall, R. A. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. _Cell_ 124, 985–996 (2006) Article  CAS  Google Scholar  * Schafmeister, C. E., Po, J. &


Verdine, G. L. An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides. _J. Am. Chem. Soc._ 122, 5891–5892 (2000) Article  CAS  Google Scholar


  * Walensky, L. D. et al. Activation of apoptosis _in vivo_ by a hydrocarbon-stapled BH3 helix. _Science_ 305, 1466–1470 (2004) Article  ADS  CAS  Google Scholar  * Del Bianco, C., Aster,


J. C. & Blacklow, S. C. Mutational and energetic studies of Notch 1 transcription complexes. _J. Mol. Biol._ 376, 131–140 (2008) Article  CAS  Google Scholar  * Aster, J. C. et al.


Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. _Mol. Cell. Biol._ 20, 7505–7515 (2000) Article  CAS  Google Scholar  * Hallis, T.


M. et al. An improved β-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification. _J. Biomol. Screen._ 12, 635–644 (2007) Article  CAS 


Google Scholar  * Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. _Science_ 313, 1929–1935 (2006) Article  ADS  CAS 


Google Scholar  * Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. _Proc. Natl Acad. Sci. USA_ 102,


15545–15550 (2005) Article  ADS  CAS  Google Scholar  * Palomero, T. et al. NOTCH1 directly regulates _c-MYC_ and activates a feed-forward-loop transcriptional network promoting leukemic


cell growth. _Proc. Natl Acad. Sci. USA_ 103, 18261–18266 (2006) Article  ADS  CAS  Google Scholar  * Weng, A. P. et al. c-Myc is an important direct target of Notch1 in T-cell acute


lymphoblastic leukemia/lymphoma. _Genes Dev._ 20, 2096–2109 (2006) Article  CAS  Google Scholar  * Rao, S. S. et al. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB


pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. _Cancer Res._ 69, 3060–3068 (2009) Article  CAS  Google Scholar  * Lewis, H. D. et al. Apoptosis in T cell


acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. _Chem. Biol._ 14, 209–219 (2007) Article  CAS  Google Scholar  *


Palomero, T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. _Nature Med._ 13, 1203–1210 (2007) Article  CAS  Google Scholar  * Becker, C. M. et


al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. _Am. J. Pathol._ 168, 2074–2084 (2006) Article  CAS  Google Scholar  * Stubbs, M. C. et


al. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. _Leukemia_ 22, 66–77 (2008) Article  CAS  Google Scholar  * Real, P.


J. et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. _Nature Med._ 15, 50–58 (2009) Article  CAS  Google Scholar  * Nam, Y., Weng, A.


P., Aster, J. C. & Blacklow, S. C. Structural requirements for assembly of the CSL·intracellular Notch1·Mastermind-like 1 transcriptional activation complex. _J. Biol. Chem._ 278,


21232–21239 (2003) Article  CAS  Google Scholar  * Chiang, M. Y. et al. Leukemia-associated _NOTCH1_ alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. _J. Clin.


Invest._ 118, 3181–3194 (2008) Article  CAS  Google Scholar  * Williams, R. M. & Im, M. N. Asymmetric synthesis of monosubstituted and α, α-disubstituted α-amino acids via


diastereoselective glycine enolate alkylations. _J. Am. Chem. Soc._ 113, 9276–9286 (1991) Article  CAS  Google Scholar  * Chen, Y. H., Yang, J. T. & Chau, K. H. Determination of the


helix and β form of proteins in aqueous solution by circular dichroism. _Biochemistry_ 13, 3350–3359 (1974) Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS We thank S.


Schreiber and the Broad Institute Chemical Biology Program for discussions and access to instrumentation; J. Rocnik for assistance in the establishment of the T-ALL murine model; A. Ferrando


for providing GSI microarray data; M. Hancock and Invitrogen for providing β-lactamase HeLa reporter clones; K. Ross and A. Subramanian for conversations and guidance about GSEA; and S.


Gupta and the Broad Institute Microarray Core. This work was supported by a Specialized Center of Research grant from the Leukaemia & Lymphoma Society (to J.E.B., J.C.A., S.C.B.), an


AACR Centennial Pre-doctoral Research Fellowship in Cancer Research (to R.E.M.), the American Society of Hematology (to J.E.B.), MCCB-NIH Training Grant No. 5T32GM007598 (to R.E.M.), the


Human Frontier Science Program (to C.D.), and the Harvard & Dana Farber Program in Cancer Chemical Biology (to J.E.B., R.E.M., G.L.V.). The project has been funded in part with Federal


funds from the National Cancer Institute’s Initiative for Chemical Genetics, National Institutes of Health, under Contract No. N01-CO-12400. Histology and immunohistochemical staining was


performed in the Dana Farber/Harvard Cancer Center Specialized Histopathology Services Core Laboratory. AUTHOR CONTRIBUTIONS R.E.M., G.L.V. and J.E.B. conceptualized the study, designed the


experiments, interpreted data, and wrote the manuscript. Design, synthesis and biological characterization of SAHM peptides was performed by R.E.M. C.D.B., J.C.A. and S.C.B. contributed key


reagents and analysed data. R.E.M., M.C., T.N.D., J.C.A., A.L.K., D.G.G. and J.E.B. established the bioluminescent T-ALL model, designed and performed _in vivo_ experiments and analysed


data. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA, Raymond E. Moellering & 


Gregory L. Verdine * Chemical Biology Program, Broad Institute of Harvard & MIT, Cambridge, Massachusetts 02142, USA, Raymond E. Moellering & James E. Bradner * Program in Cancer


Chemical Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA, Raymond E. Moellering, Gregory L. Verdine & James E. Bradner * Division of Hematology, Brigham &


Women’s Hospital, Melanie Cornejo & D. Gary Gilliland * Department of Pathology, Brigham & Women’s Hospital, Cristina Del Bianco, Jon C. Aster & Stephen C. Blacklow * Department


of Pediatric Oncology, Dana-Farber Cancer Institute and Children’s Hospital, Tina N. Davis & Andrew L. Kung * Howard Hughes Medical Institute,, D. Gary Gilliland * Division of


Hematologic Neoplasia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA, James E. Bradner Authors * Raymond E. Moellering View author publications You


can also search for this author inPubMed Google Scholar * Melanie Cornejo View author publications You can also search for this author inPubMed Google Scholar * Tina N. Davis View author


publications You can also search for this author inPubMed Google Scholar * Cristina Del Bianco View author publications You can also search for this author inPubMed Google Scholar * Jon C.


Aster View author publications You can also search for this author inPubMed Google Scholar * Stephen C. Blacklow View author publications You can also search for this author inPubMed Google


Scholar * Andrew L. Kung View author publications You can also search for this author inPubMed Google Scholar * D. Gary Gilliland View author publications You can also search for this author


inPubMed Google Scholar * Gregory L. Verdine View author publications You can also search for this author inPubMed Google Scholar * James E. Bradner View author publications You can also


search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to Gregory L. Verdine or James E. Bradner. ETHICS DECLARATIONS COMPETING INTERESTS [COMPETING INTERESTS:


G.L.V. is a shareholder in and paid consultant of Aileron Therapeutics, which has been granted a license by Harvard University and the Dana Farber Cancer Institute to develop the stapled


peptide technology.] SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION This file contains Supplementary Figures 1 - 8 with Legends and Supplementary Tables 1 - 2. (PDF 3034 kb) POWERPOINT


SLIDES POWERPOINT SLIDE FOR FIG. 1 POWERPOINT SLIDE FOR FIG. 2 POWERPOINT SLIDE FOR FIG. 3 POWERPOINT SLIDE FOR FIG. 4 POWERPOINT SLIDE FOR FIG. 5 RIGHTS AND PERMISSIONS Reprints and


permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Moellering, R., Cornejo, M., Davis, T. _et al._ Direct inhibition of the NOTCH transcription factor complex. _Nature_ 462, 182–188 (2009).


https://doi.org/10.1038/nature08543 Download citation * Received: 29 January 2009 * Accepted: 25 September 2009 * Issue Date: 12 November 2009 * DOI: https://doi.org/10.1038/nature08543


SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative